Table 2.
Adverse events | CTCAE | |||
---|---|---|---|---|
Patients (n = 44) | ||||
Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
Neutropenia | 1 (2.3) | 5 (11.4) | 8 (18.2) | 7 (15.9) |
Febrile neutropenia | 0 | 0 | 2 (4.5) | 0 |
Anemia | 12 (27.3) | 5 (11.4) | 0 | 0 |
Thrombocytopenia | 0 | 0 | 0 | 0 |
Nausea | 7 (15.9) | 2 (4.5) | 4 (9.1) | 0 |
Vomiting | 5 (11.4) | 2 (4.5) | 4 (9.1) | 0 |
Diarrhea | 3 (6.8) | 2 (4.5) | 0 | 0 |
Constipation | 1 (2.3) | 0 | 0 | 0 |
Peripheral neuropathy | 3 (6.8) | 0 | 0 | 0 |
Stomatitis | 4 (9.1) | 2 (4.5) | 0 | 0 |
Alopecia | 1 (2.3) | 0 | 0 | 0 |
Gastrointestinal bleeding | 0 | 0 | 1 (2.3) | 0 |
Categorical variables are listed as n (%).
Abbreviation: CTCAE, Common Terminology Criteria for Adverse Events ver 4.0.